Table of Content

1 Neurotrophins Market Overview
1.1 Product Overview and Scope of Neurotrophins
1.2 Neurotrophins Segment by Type
1.2.1 Global Neurotrophins Market Value Comparison by Type (2024-2034)
1.2.2 Nerve Growth Factor
1.2.3 Brain-Derived Neurotrophic Factor
1.2.4 Dehydroepiandrosterone Sulfate
1.2.5 Other
1.3 Neurotrophins Segment by Application
1.3.1 Global Neurotrophins Market Value by Application: (2024-2034)
1.3.2 Alzheimer'S Disease
1.3.3 Amyotrophic Lateral Sclerosis
1.3.4 Parkinson'S Disease
1.3.5 Other
1.4 Global Neurotrophins Market Size Estimates and Forecasts
1.4.1 Global Neurotrophins Revenue 2018-2034
1.4.2 Global Neurotrophins Sales 2018-2034
1.4.3 Global Neurotrophins Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Neurotrophins Market Competition by Manufacturers
2.1 Global Neurotrophins Sales Market Share by Manufacturers (2018-2024)
2.2 Global Neurotrophins Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Neurotrophins Average Price by Manufacturers (2018-2024)
2.4 Global Neurotrophins Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Neurotrophins, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Neurotrophins, Product Type & Application
2.7 Neurotrophins Market Competitive Situation and Trends
2.7.1 Neurotrophins Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Neurotrophins Players Market Share by Revenue
2.7.3 Global Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurotrophins Retrospective Market Scenario by Region
3.1 Global Neurotrophins Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Neurotrophins Global Neurotrophins Sales by Region: 2018-2034
3.2.1 Global Neurotrophins Sales by Region: 2018-2024
3.2.2 Global Neurotrophins Sales by Region: 2024-2034
3.3 Global Neurotrophins Global Neurotrophins Revenue by Region: 2018-2034
3.3.1 Global Neurotrophins Revenue by Region: 2018-2024
3.3.2 Global Neurotrophins Revenue by Region: 2024-2034
3.4 North America Neurotrophins Market Facts & Figures by Country
3.4.1 North America Neurotrophins Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Neurotrophins Sales by Country (2018-2034)
3.4.3 North America Neurotrophins Revenue by Country (2018-2034)
3.4.4 United States
3.4.5 Canada
3.5 Europe Neurotrophins Market Facts & Figures by Country
3.5.1 Europe Neurotrophins Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Neurotrophins Sales by Country (2018-2034)
3.5.3 Europe Neurotrophins Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Neurotrophins Market Facts & Figures by Country
3.6.1 Asia Pacific Neurotrophins Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Neurotrophins Sales by Country (2018-2034)
3.6.3 Asia Pacific Neurotrophins Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Neurotrophins Market Facts & Figures by Country
3.7.1 Latin America Neurotrophins Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Neurotrophins Sales by Country (2018-2034)
3.7.3 Latin America Neurotrophins Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Neurotrophins Market Facts & Figures by Country
3.8.1 Middle East and Africa Neurotrophins Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Neurotrophins Sales by Country (2018-2034)
3.8.3 Middle East and Africa Neurotrophins Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Neurotrophins Sales by Type (2018-2034)
4.1.1 Global Neurotrophins Sales by Type (2018-2024)
4.1.2 Global Neurotrophins Sales by Type (2024-2034)
4.1.3 Global Neurotrophins Sales Market Share by Type (2018-2034)
4.2 Global Neurotrophins Revenue by Type (2018-2034)
4.2.1 Global Neurotrophins Revenue by Type (2018-2024)
4.2.2 Global Neurotrophins Revenue by Type (2024-2034)
4.2.3 Global Neurotrophins Revenue Market Share by Type (2018-2034)
4.3 Global Neurotrophins Price by Type (2018-2034)
5 Segment by Application
5.1 Global Neurotrophins Sales by Application (2018-2034)
5.1.1 Global Neurotrophins Sales by Application (2018-2024)
5.1.2 Global Neurotrophins Sales by Application (2024-2034)
5.1.3 Global Neurotrophins Sales Market Share by Application (2018-2034)
5.2 Global Neurotrophins Revenue by Application (2018-2034)
5.2.1 Global Neurotrophins Revenue by Application (2018-2024)
5.2.2 Global Neurotrophins Revenue by Application (2024-2034)
5.2.3 Global Neurotrophins Revenue Market Share by Application (2018-2034)
5.3 Global Neurotrophins Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Johnson＆Johnson
6.1.1 Johnson＆Johnson Corporation Information
6.1.2 Johnson＆Johnson Description and Business Overview
6.1.3 Johnson＆Johnson Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Johnson＆Johnson Neurotrophins Product Portfolio
6.1.5 Johnson＆Johnson Recent Developments/Updates
6.2 Lonza Groups
6.2.1 Lonza Groups Corporation Information
6.2.2 Lonza Groups Description and Business Overview
6.2.3 Lonza Groups Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Lonza Groups Neurotrophins Product Portfolio
6.2.5 Lonza Groups Recent Developments/Updates
6.3 FibroGen
6.3.1 FibroGen Corporation Information
6.3.2 FibroGen Description and Business Overview
6.3.3 FibroGen Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.3.4 FibroGen Neurotrophins Product Portfolio
6.3.5 FibroGen Recent Developments/Updates
6.4 Scil Proteins GmbH
6.4.1 Scil Proteins GmbH Corporation Information
6.4.2 Scil Proteins GmbH Description and Business Overview
6.4.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Scil Proteins GmbH Neurotrophins Product Portfolio
6.4.5 Scil Proteins GmbH Recent Developments/Updates
6.5 Merck Serono
6.5.1 Merck Serono Corporation Information
6.5.2 Merck Serono Description and Business Overview
6.5.3 Merck Serono Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Merck Serono Neurotrophins Product Portfolio
6.5.5 Merck Serono Recent Developments/Updates
6.6 Scil Proteins GmbH
6.6.1 Scil Proteins GmbH Corporation Information
6.6.2 Scil Proteins GmbH Description and Business Overview
6.6.3 Scil Proteins GmbH Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Scil Proteins GmbH Neurotrophins Product Portfolio
6.6.5 Scil Proteins GmbH Recent Developments/Updates
6.7 PeproTech
6.6.1 PeproTech Corporation Information
6.6.2 PeproTech Description and Business Overview
6.6.3 PeproTech Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.4.4 PeproTech Neurotrophins Product Portfolio
6.7.5 PeproTech Recent Developments/Updates
6.8 GE Healthcare
6.8.1 GE Healthcare Corporation Information
6.8.2 GE Healthcare Description and Business Overview
6.8.3 GE Healthcare Neurotrophins Sales, Revenue and Gross Margin (2018-2024)
6.8.4 GE Healthcare Neurotrophins Product Portfolio
6.8.5 GE Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Neurotrophins Industry Chain Analysis
7.2 Neurotrophins Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Neurotrophins Production Mode & Process
7.4 Neurotrophins Sales and Marketing
7.4.1 Neurotrophins Sales Channels
7.4.2 Neurotrophins Distributors
7.5 Neurotrophins Customers
8 Neurotrophins Market Dynamics
8.1 Neurotrophins Industry Trends
8.2 Neurotrophins Market Drivers
8.3 Neurotrophins Market Challenges
8.4 Neurotrophins Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurotrophins Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Neurotrophins Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Neurotrophins Market Competitive Situation by Manufacturers in 2022
Table 4. Global Neurotrophins Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Neurotrophins Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Neurotrophins Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Neurotrophins Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Neurotrophins Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Neurotrophins, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Neurotrophins, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Neurotrophins, Product Type & Application
Table 12. Global Key Manufacturers of Neurotrophins, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Neurotrophins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurotrophins as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Neurotrophins Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Neurotrophins Sales by Region (2018-2024) & (K Units)
Table 18. Global Neurotrophins Sales Market Share by Region (2018-2024)
Table 19. Global Neurotrophins Sales by Region (2024-2034) & (K Units)
Table 20. Global Neurotrophins Sales Market Share by Region (2024-2034)
Table 21. Global Neurotrophins Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Neurotrophins Revenue Market Share by Region (2018-2024)
Table 23. Global Neurotrophins Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Neurotrophins Revenue Market Share by Region (2024-2034)
Table 25. North America Neurotrophins Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Neurotrophins Sales by Country (2018-2024) & (K Units)
Table 27. North America Neurotrophins Sales by Country (2024-2034) & (K Units)
Table 28. North America Neurotrophins Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Neurotrophins Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Neurotrophins Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Neurotrophins Sales by Country (2018-2024) & (K Units)
Table 32. Europe Neurotrophins Sales by Country (2024-2034) & (K Units)
Table 33. Europe Neurotrophins Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Neurotrophins Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Neurotrophins Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Neurotrophins Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Neurotrophins Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Neurotrophins Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Neurotrophins Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Neurotrophins Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Neurotrophins Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Neurotrophins Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Neurotrophins Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Neurotrophins Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Neurotrophins Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Neurotrophins Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Neurotrophins Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Neurotrophins Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Neurotrophins Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Neurotrophins Sales (K Units) by Type (2018-2024)
Table 51. Global Neurotrophins Sales (K Units) by Type (2024-2034)
Table 52. Global Neurotrophins Sales Market Share by Type (2018-2024)
Table 53. Global Neurotrophins Sales Market Share by Type (2024-2034)
Table 54. Global Neurotrophins Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Neurotrophins Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Neurotrophins Revenue Market Share by Type (2018-2024)
Table 57. Global Neurotrophins Revenue Market Share by Type (2024-2034)
Table 58. Global Neurotrophins Price (US$/Unit) by Type (2018-2024)
Table 59. Global Neurotrophins Price (US$/Unit) by Type (2024-2034)
Table 60. Global Neurotrophins Sales (K Units) by Application (2018-2024)
Table 61. Global Neurotrophins Sales (K Units) by Application (2024-2034)
Table 62. Global Neurotrophins Sales Market Share by Application (2018-2024)
Table 63. Global Neurotrophins Sales Market Share by Application (2024-2034)
Table 64. Global Neurotrophins Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Neurotrophins Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Neurotrophins Revenue Market Share by Application (2018-2024)
Table 67. Global Neurotrophins Revenue Market Share by Application (2024-2034)
Table 68. Global Neurotrophins Price (US$/Unit) by Application (2018-2024)
Table 69. Global Neurotrophins Price (US$/Unit) by Application (2024-2034)
Table 70. Johnson＆Johnson Corporation Information
Table 71. Johnson＆Johnson Description and Business Overview
Table 72. Johnson＆Johnson Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. Johnson＆Johnson Neurotrophins Product
Table 74. Johnson＆Johnson Recent Developments/Updates
Table 75. Lonza Groups Corporation Information
Table 76. Lonza Groups Description and Business Overview
Table 77. Lonza Groups Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. Lonza Groups Neurotrophins Product
Table 79. Lonza Groups Recent Developments/Updates
Table 80. FibroGen Corporation Information
Table 81. FibroGen Description and Business Overview
Table 82. FibroGen Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. FibroGen Neurotrophins Product
Table 84. FibroGen Recent Developments/Updates
Table 85. Scil Proteins GmbH Corporation Information
Table 86. Scil Proteins GmbH Description and Business Overview
Table 87. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Scil Proteins GmbH Neurotrophins Product
Table 89. Scil Proteins GmbH Recent Developments/Updates
Table 90. Merck Serono Corporation Information
Table 91. Merck Serono Description and Business Overview
Table 92. Merck Serono Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Merck Serono Neurotrophins Product
Table 94. Merck Serono Recent Developments/Updates
Table 95. Scil Proteins GmbH Corporation Information
Table 96. Scil Proteins GmbH Description and Business Overview
Table 97. Scil Proteins GmbH Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Scil Proteins GmbH Neurotrophins Product
Table 99. Scil Proteins GmbH Recent Developments/Updates
Table 100. PeproTech Corporation Information
Table 101. PeproTech Description and Business Overview
Table 102. PeproTech Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. PeproTech Neurotrophins Product
Table 104. PeproTech Recent Developments/Updates
Table 105. GE Healthcare Corporation Information
Table 106. GE Healthcare Description and Business Overview
Table 107. GE Healthcare Neurotrophins Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. GE Healthcare Neurotrophins Product
Table 109. GE Healthcare Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Neurotrophins Distributors List
Table 113. Neurotrophins Customers List
Table 114. Neurotrophins Market Trends
Table 115. Neurotrophins Market Drivers
Table 116. Neurotrophins Market Challenges
Table 117. Neurotrophins Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Neurotrophins
Figure 2. Global Neurotrophins Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Neurotrophins Market Share by Type in 2022 & 2034
Figure 4. Nerve Growth Factor Product Picture
Figure 5. Brain-Derived Neurotrophic Factor Product Picture
Figure 6. Dehydroepiandrosterone Sulfate Product Picture
Figure 7. Other Product Picture
Figure 8. Global Neurotrophins Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Neurotrophins Market Share by Application in 2022 & 2034
Figure 10. Alzheimer'S Disease
Figure 11. Amyotrophic Lateral Sclerosis
Figure 12. Parkinson'S Disease
Figure 13. Other
Figure 14. Global Neurotrophins Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Neurotrophins Market Size (2018-2034) & (US$ Million)
Figure 16. Global Neurotrophins Sales (2018-2034) & (K Units)
Figure 17. Global Neurotrophins Average Price (US$/Unit) & (2018-2034)
Figure 18. Neurotrophins Report Years Considered
Figure 19. Neurotrophins Sales Share by Manufacturers in 2022
Figure 20. Global Neurotrophins Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Neurotrophins Players: Market Share by Revenue in 2022
Figure 22. Neurotrophins Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Neurotrophins Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Neurotrophins Sales Market Share by Country (2018-2034)
Figure 25. North America Neurotrophins Revenue Market Share by Country (2018-2034)
Figure 26. United States Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Neurotrophins Sales Market Share by Country (2018-2034)
Figure 29. Europe Neurotrophins Revenue Market Share by Country (2018-2034)
Figure 30. Germany Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Neurotrophins Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Neurotrophins Revenue Market Share by Region (2018-2034)
Figure 37. China Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. China Taiwan Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Latin America Neurotrophins Sales Market Share by Country (2018-2034)
Figure 47. Latin America Neurotrophins Revenue Market Share by Country (2018-2034)
Figure 48. Mexico Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Brazil Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Argentina Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Middle East & Africa Neurotrophins Sales Market Share by Country (2018-2034)
Figure 52. Middle East & Africa Neurotrophins Revenue Market Share by Country (2018-2034)
Figure 53. Turkey Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. UAE Neurotrophins Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. Global Sales Market Share of Neurotrophins by Type (2018-2034)
Figure 57. Global Revenue Market Share of Neurotrophins by Type (2018-2034)
Figure 58. Global Neurotrophins Price (US$/Unit) by Type (2018-2034)
Figure 59. Global Sales Market Share of Neurotrophins by Application (2018-2034)
Figure 60. Global Revenue Market Share of Neurotrophins by Application (2018-2034)
Figure 61. Global Neurotrophins Price (US$/Unit) by Application (2018-2034)
Figure 62. Neurotrophins Value Chain
Figure 63. Neurotrophins Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed